Used in biomedical research to quantify TRPA1 protein levels in cell or tissue samples, this ELISA kit enables scientists to study the role of TRPA1 in pain signaling, inflammation, and neurosensory processes. It is widely applied in preclinical studies related to chronic pain, asthma, and neurodegenerative diseases, helping assess target engagement and disease progression. The kit supports drug development efforts focused on TRPA1 antagonists or modulators by providing a reliable method to measure protein expression changes in response to treatments.